Actively Recruiting
Translational Cancer Observational Protocol
Led by IRCCS San Raffaele · Updated on 2023-12-13
1250
Participants Needed
1
Research Sites
2609 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Observational study on relapse occurrence and on the quality of life in patients who underwent nephroureterectomy surgery
CONDITIONS
Official Title
Translational Cancer Observational Protocol
Who Can Participate
Eligibility Criteria
You may qualify if you...
- 18 years or older
- Diagnosis of upper tract urothelial cancer
- Scheduled for cancer removal through nephroureterectomy surgery
- Ability to read and sign the informed consent
You will not qualify if you...
- Younger than 18 years
- No diagnosis of upper tract urothelial cancer
- Unable to read or sign the informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
IRCCS Ospedale San Raffaele
Milan, MI, Italy, 20132
Actively Recruiting
Research Team
F
Francesco Montorsi, MD.
CONTACT
F
Francesco Fiorio, MSC
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here